During the past decade, Christie Hospital and Holt Radium Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Christie Hospital and Holt Radium Institute" are "Acromegaly" (1 trials) and "Carcinoid Syndrome" (1 trials). Many other conditions were trialed in "Christie Hospital and Holt Radium Institute" in a lesser frequency.

Most popular intervention types in "Christie Hospital and Holt Radium Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BIM 23A760" (1 trials), "Pegvisomant" (1 trials) and "lanreotide (Autogel formulation)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christie Hospital and Holt Radium Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Christie Hospital and Holt Radium Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Christie Hospital and Holt Radium Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Christie Hospital and Holt Radium Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".